XML 76 R55.htm IDEA: XBRL DOCUMENT v3.25.0.1
Collaboration and License Agreements (Additional Information) (Details) - USD ($)
$ in Thousands
 1 Months Ended 12 Months Ended
Oct. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Revenue   $ 7,873 $ 0
Research and development   99,119 71,289
Accounts receivable   $ 12,722 $ 0
Revenue, performance obligation satisfied over time, method used, description   The Company expects to recognize all of this balance as revenue as research and development services are provided over the next 4 years.  
Contract Liability   $ 11,100  
Contract Assets   0  
Capitalized contract cost   7,100  
Milestones require payments   $ 6,000  
Number of milestones   two  
Innovent      
Repayments of NonRefundable Upfront Cash Payment   $ 12,000  
Received a non-refundable upfront cash payment   17,000  
Achievement of commercial milestones   105,000  
Nk [Member]      
Accounts receivable   100  
Received a non-refundable upfront cash payment $ 25,000    
Achievement of commercial milestones $ 35,000    
AnHeart [Member]      
Contract with customer liability revenue recognized   200  
Research and development service revenue      
Revenue   5,787  
Research and development   9,900  
Contract Liability   26,689  
Research and development service revenue | Innovent      
Revenue   3,100  
Accounts receivable   12,600  
Company is owed in milestone payments   12,000  
Research and development service revenue | Nk [Member]      
Revenue   2,700  
License [Member]      
Revenue   2,100  
License [Member] | Innovent      
Revenue   $ 2,100